Notably, in RA patients with low disease activity, a 12-week course of low-dose sirolimus (0.5 mg every other day) also exhibited a favorable safety profile, elevating Treg levels and enhancing clinical outcomes without evidence of toxicitiessuch as hemorrhagic cystitis or liver fibrosisthat are associated with certain conventional immunosuppressive agents (142)
Evidence suggests that peptides like Thymosin Alpha1, BPC157, KPV, and Thymosin Beta 4 can modulate immune responses, promote healing, and support gut health
doi:10.1002/jor.21107 Bock-Marquette I, Saxena A, White MD, DiMaio JM, Srivastava D
Schedule a consultation with Florida Surgery & Weight Loss Center to discuss GLOW Blend peptide therapy, recovery support, mobility support, skin health, collagen support, and personalized wellness-focused care